S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NYSEARCA:JDIV

JPMorgan U.S. Dividend ETF Stock Forecast, Price & News

$28.04
-0.06 (-0.21 %)
(As of 01/22/2021 12:00 AM ET)
Add
Today's Range
$27.87
Now: $28.04
$28.04
50-Day Range
$26.52
MA: $27.47
$28.28
52-Week Range
$16.20
Now: $28.04
$29.09
Volume1,300 shs
Average Volume4,864 shs
Market Capitalization$15.42 million
P/E RatioN/A
Dividend Yield4.41%
BetaN/A

Geographic Exposure of JDIV

Currency Exposure of JDIV

Sector Exposure of JDIV

Industry Exposure of JDIV


Basic Details

Issuer JPMorgan
Fund NameJPMorgan U.S. Dividend ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:JDIV
Inception Date11/8/2017
Fund ManagerYazann Romahi, Jonathan Msika, Joe Staines, Steven Yegang Wu, Aijaz Hussain
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkJP Morgan US Dividend Index
CategoryStrategy
FocusHigh Dividend Yield
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$36.74 million
Average Daily Volume$4,591.60
Discount/Premium-0.01%

ETF Expenses

Management Fee0.23%
Other Expenses0.29%
Total Expenses0.52%
Fee Waiver-0.40%
Net Expenses0.12%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investment Management Inc.
AdvisorJ.P. Morgan Investment Management Inc.
CustodianJPMorgan Chase Bank, N.A.
DistributorJPMorgan Distribution Services, Inc.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerJane Street
$28.04
-0.06 (-0.21 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive JDIV News and Ratings via Email

Sign-up to receive the latest news and ratings for JDIV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











JPMorgan U.S. Dividend ETF (NYSEARCA:JDIV) Frequently Asked Questions

How has JPMorgan U.S. Dividend ETF's stock been impacted by COVID-19 (Coronavirus)?

JPMorgan U.S. Dividend ETF's stock was trading at $22.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, JDIV stock has increased by 26.7% and is now trading at $28.04.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than JPMorgan U.S. Dividend ETF?

Wall Street analysts have given JPMorgan U.S. Dividend ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but JPMorgan U.S. Dividend ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Is JPMorgan U.S. Dividend ETF a good dividend stock?

JPMorgan U.S. Dividend ETF pays an annual dividend of $1.22 per share and currently has a dividend yield of 4.41%. JDIV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View JPMorgan U.S. Dividend ETF's dividend history.

What other stocks do shareholders of JPMorgan U.S. Dividend ETF own?

What is JPMorgan U.S. Dividend ETF's stock symbol?

JPMorgan U.S. Dividend ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "JDIV."

How do I buy shares of JPMorgan U.S. Dividend ETF?

Shares of JDIV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is JPMorgan U.S. Dividend ETF's stock price today?

One share of JDIV stock can currently be purchased for approximately $28.04.

How big of a company is JPMorgan U.S. Dividend ETF?

JPMorgan U.S. Dividend ETF has a market capitalization of $15.42 million.

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.